Why This Analyst Sees Care.com Fetching Up To $16/Share In Potential Sale

Loading...
Loading...

Care.com Inc CRCM, an online platform to help people find and manage family care, is reportedly undertaking a strategic review and could sell itself in the $14 to $16 per share range, according to BTIG.

The Analyst

BTIG analyst Marvin Fong maintains a Buy rating on Care's stock with a $13 price target.

The Thesis

Care.com appears to be "ripe for a possible sale" of itself given multiple vacant positions in senior management along with frustrated shareholders and pressure from activist investor Engine Capital, Fong wrote in a note.

On the other hand, the company does have a leading platform within an attractive market with a short list of potential buyers, including IAC/InterActiveCorp IAC, Internet Brands, or a private equity group.

Fong said a potential buyer would appreciate Care's more enhanced background checks and management's strategy to fight back against recent negative press. The company also boasts a "sound" balance sheet and positive free cash flow.

At this point a sale is "more likely than not" to take place and a price tag of $14 to $16 implies a multiple of 22 to 26 times 2020 estimated Adjusted EBITDA.

Price Action

Shares of Care.com were trading higher by 8.4% Monday at $12.13.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorM&AHealth CareAnalyst RatingsGeneralbtigFamily CareMargin Fong
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...